Our proposal seeks to develop an individualized HIV cure strategy targeting the component of the HIV reservoir that is not controlled by the host upon reactivation. A team of academic and industry partners will test several individualized strategies including tailored viral reactivation and personalized approaches to develop antibody and cell-mediated interventions designed against the unique features of each individual’s persistent HIV during antiretroviral therapy.